Skip to main content

Floragenex Lands Investment from Seed Firm

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agricultural genomics company Floragenex has received a strategic investment from Illinois Foundation Seeds, a research and licensing company focused on corn technologies.

Floragenex did not disclose the amount of the investment, which gives Illinois Foundation Seeds access to technology for research and breeding efforts in the dent corn and sweet corn markets.

Based in Eugene and Portland Ore., Floragenex has an exclusive license to restriction site associated DNA, or RAD, sample preparation and sequencing technology that was developed at the University of Oregon.

The RAD technique supports researchers seeking SNP information in species that lack assembled reference genomes.

As part of the investment agreement, Tim Johnson, division president of Illinois Foundation Seeds, will join the board at Floragenex to “provide support as the company continues to grow into new markets and reach new customers,” the company said.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.